TRIM63 and malignant colon neoplasm: Next, we treated C2C12 cells with conditioned media (CM) from CT26 colon cancer cells and evaluated the mRNA levels of muscle-specific E3 ubiquitin ligases, Atrogin-1 and MuRF1, which are key markers of skeletal muscle atrophy (6, 27).